Hatteras Venture Partners
Hatteras Venture Partners is a venture capital firm dedicated to building transformational human medicine companies that benefit patients and the professionals who serve them. With over two decades of experience, Hatteras focuses on early-stage investments in healthcare innovation, including biopharmaceuticals, medical devices, diagnostics, and healthcare IT. The firm is committed to improving health through transformative therapies and disruptive technologies.
Hatteras Venture Partners
Portfolio
Developing an extracardiac, extravascular approach to cardiac pacing and defibrillation.
#Med Devices
Delivers improved health outcomes, member experience, and cost savings with Advance Care Planning solutions.
#Healthcare IT
Developing engineered viral vectors for gene therapy using structure-inspired design of AAV vectors.
#Biopharma
Developing small-molecule therapies to address significant unmet needs in oncology.
#Biopharma
Provides on-demand clinical research infrastructure to enable large physician practices to offer clinical trial participation.
#Healthcare IT
Developing small molecules that target functional 3D RNA structures to treat human disease.
#Biopharma
Developing an integrated embolic protection platform to improve the safety and efficacy of catheter-based interventions.
#Med Devices